Longitudinal Knowledge Assessment
Larry Dean, MD, Chair
Dr. Dean is currently a professor of medicine and surgery at the University of Washington (UW) School of Medicine and Director of the UW Medicine Regional Heart Center in Seattle, Washington. He is board certified in internal medicine, cardiovascular disease and interventional cardiology.
Previously, Dr. Dean was a professor of medicine at the University of Alabama (UAB) School of Medicine where he also served as an assistant medical director of UAB Hospital. While there he practiced general and interventional cardiology and was involved in the early development of intra coronary stents.
Dr. Dean specializes in interventional cardiology and is widely published in that field. He is a fellow of the American College of Cardiology, the American Heart Association and is a Master Interventionalist of the Society for Cardiovascular Angiography and Interventions (SCAI). He is also a past president of SCAI. In addition he is a member of the American Association for Physician Leadership and the American Medical Informatics Association.
He received his undergraduate degree and his medical degree from the UAB. Following medical school, he served his internship and residency at the UW School of Medicine and received cardiology training, including interventional cardiology, at the UAB School of Medicine. He also holds a certificate in medical management from the UW.
As of July 2022, Dr. Dean reported the following external relationships:
Funding for clinical trial expenses and staff, paid to the University of Washington School of Medicine, from the following company:
- Edwards Lifesciences, for trials evaluating the SAPIEN heart valve (PARTNER II trials)
Dr. Dean serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American College of Cardiology, Transcatheter Valve Therapy Registry Stakeholders Committee, receiving honoraria and reimbursement for travel expenses
- The Society for Cardiovascular Angiography and Interventions, Political Action Committee; Structural Heart Disease Committee, without compensation
Naser Ammash, MD, FACC, FASE
Dr. Naser Ammash is a Professor of Medicine, Mayo Clinic College of Medicine, and a Consultant in Cardiovascular (CV) Department at Mayo Clinic, Rochester since 1995. Dr. Ammash is the current CEO of Sheik Shakhbout Medical City, a joint venture between Mayo clinic and Abu Dhabi heath authority. He was one of the physician leaders of project “Gazelle” for the activation of Sheik Shakhbout Medical City. Dr Ammash is the immediate past Practice Chair of the CV Department at Mayo clinic Rochester and served as Chair of the CV Clinical Practice Committee for Rochester and Mayo clinic enterprise (2014-2018). In that role, he oversaw and directly managed the restructuring of the inpatient and outpatient practice into an integrated Patient-Centric Disease Orientated, at times multispecialty, team-based services. He also led practice integration and enhancement with cardiac surgery developing differentiated and integrated care delivery services with facilitated access.
Dr. Ammash has a Silver Level Certification from the Quality academy and was a member of the Midwest Specialty Care CPC Space and Remodeling Subcommittee (2016-2018). His prior leadership experience includes; co-director of the Echocardiography laboratory (2011-2014), chair of Echocardiography Clinical Practice Committee (2011-2014), director of Echocardiography training program (2008-2011). Dr. Ammash is Board Certified in Cardiovascular Diseases, with subspecialty certification in Adult Congenital Heart Disease and Echocardiography. He attended the American University of Beirut- Lebanon and moved to the United States in 1987. He joined the Mayo Clinic in 1994.
Dr Ammash currently serves on the American Board of Internal Medicine test approval committee for the Cardiovascular board after being a member of the testing writing committee for the board certification examination until 2019. His resume includes more than 150 peer-reviewed published articles and chapter books in addition to being an invited speaker to numerous national and international continuous medical education meetings including many in the middle east and gulf regions where he is the director of an annual Cardiovascular review course in Bahrain since 2014.
As of August 2022, Dr. Ammash reported the following external relationships:
Work as an author or editor for the following company, with compensation as listed:
- UpToDate®, receiving compensation for authorship
Marie Gerhard-Herman, MD
As of March 2021, Dr. Gerhard-Herman reported the following external relationships:
Dr. Gerhard-Herman serves in significant roles with the following organization(s), receiving reimbursement or compensation as listed:
Progeria Research Foundation, grant funding provided to Brigham and Women’s Hospital for vascular ultrasound imaging to assess phenotype and response to therapy in children with Hutchinson-Gilford (HG) progeria syndrome; receiving salary support.
As of June 2023, Dr. Gerhard-Herman reported the following external relationships:
Dr. Gerhard-Herman serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The National Institutes of Health, grant funding provided to Brigham and Women’s Hospital for research on artery on a chip, receiving salary support
- Progeria Research Foundation, grant funding provided to Brigham and Women’s Hospital for vascular ultrasound imaging to assess phenotype and response to therapy in children with Hutchinson-Gilford progeria syndrome, receiving salary support
Barbara Hutchinson, MD, PhD, FACC
Dr. Hutchinson is the managing partner of Chesapeake Cardiac Care, P.A., a cardiology practice located in Annapolis, Maryland. She is board certified in both cardiovascular disease and sleep medicine. Patients from all over the world seek her out, and she is a noted speaker on heart disease in women and how sleep affects heart health. Dr. Hutchinson is also an instructor in the Department of Internal Medicine at University of Maryland Hospital in Baltimore.
Previously, Dr. Hutchinson was Medical Director of the Heart and Vascular Unit at Anne Arundel Medical Center and Intensivist at Mercy Medical Center. She was the first African American to hold the title of Chief Resident in Internal Medicine at the University of Maryland Hospital. She was also a lecturer in pharmacology at the University of District of Columbia in the Department of Respiratory Therapy.
Dr. Hutchinson is currently President-Elect of the Association of Black Cardiologists, and a Fellow of the American College of Cardiology. Additionally, Dr. Hutchinson is the recipient of numerous awards, including the Caribbean American Heritage Award, the Innovator of the Year, the Enterprising Woman of the Year Award, the Impact Award and the Brava Award.
Dr. Hutchinson was born in Trinidad and Tobago and she earned her Bachelor of Science in Chemistry at the University of the West Indies. Upon graduation, she moved to the United States, became an American citizen, and earned a Doctor of Philosophy in Cardiovascular Pharmacology from Howard University in Washington, D.C., followed by a medical degree and subsequent fellowship in cardiology from the University of Maryland in Baltimore.
As of June 2022, Dr. Hutchinson reported no ongoing external relationships.
Andrea Russo, MD
Dr. Russo, board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology, is Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief of the Division of Cardiology, Director of Electrophysiology and Arrhythmia Services and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Health Center in Camden, New Jersey. She previously joined the faculty at the University of Pennsylvania in 1997 and then the University of Medicine and Dentistry in New Jersey (UMDNJ)/Robert Wood Johnson Medical School at Cooper University Hospital in Camden, New Jersey. in 2009.
Dr. Russo serves as Chair of the American Board of Internal Medicine (ABIM) Cardiovascular Disease Board and member of the ABIM Council. She previously served on the ABIM Cardiovascular Test Writing Committee and the American Board of Medical Specialty Continuing Board Certification Vision for the Future Commission.
Dr. Russo earned her medical degree from the State University of New York Upstate Medical Center in Syracuse and completed her internship and residency at the Medical College of Philadelphia, Pennsylvania. She completed her fellowship in cardiology and electrophysiology, both at Cooper University Hospital in Camden, New Jersey.
As of November 2022, Dr. Russo reported the following ongoing external relationships:
Funding for clinical trial expenses and staff, paid to Cooper University, from the following companies:
- Boston Scientific
- Kaestra
- Medi-Lynx
- Medtronic
Service on data and safety monitoring boards for the following company, with honoraria:
- Biosense Webster Inc.
Service on a research-related steering committee for the following companies, without compensation:
- Bayer
- Medtronic
Research-related consulting for the following companies, with honoraria:
- Abbott
- Atricure
- Biosense Webster Inc.
- Medtronic
- PaceMate
Industry-supported continuing medical education supported by the following, with compensation for travel expenses and honoraria:
- Medtronic
- Sanofi
Work as an author or editor for the following company, with compensation as listed:
- UpToDate®, receiving compensation as an editor and author for chapters related to implantable cardioverter defibrillator therapy
Dr. Russo serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- The Heart Rhythm Society, conference speaker, receiving reimbursement for travel expenses
Traditional, 10-Year MOC Exam
Dimitri C. Cassimatis, MD, FACC, Chair
Dr. Cassimatis provides inpatient and outpatient non-invasive cardiology care at Emory University Hospital Midtown (EUHM) in Atlanta. He is currently the Martha West Looney Chief of Medicine at EUHM, a role he assumed in 2020, after serving for more than a decade as the cardiology medical director of the Coronary Care Unit. In addition to his clinical and administrative work, Dr. Cassimatis co-directs the first-year medical student Cardiovascular Pathophysiology course at the Emory University School of Medicine and is one of the school’s Small Group Advisors.
Before joining Emory in 2010, Dr. Cassimatis spent 11 years as a physician in the United States Army. He received his medical degree from Harvard University and his post-graduate training at Walter Reed Army Medical Center. He currently holds ABIM Board Certification in Internal Medicine (since 2002) and Cardiology (since 2005).
As of July 2022, Dr. Cassimatis reported the following external relationships:
Dr. Cassimatis serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- The Medical Association of Atlanta, Board of Trustees Member receiving reimbursement for travel expenses.
Dr. Cassimatis teaches a cardiology pathophysiology course for Emory University medical students, and also teaches cardiology fellows in clinical practice. He is also a faculty advisor for the cardiology chapter of the First Aid for USMLE Step 1 and First Aid for the USMLE Step 2 CK.
Mina R. Chung, MD
Dr. Chung is board certified in internal medicine, cardiovascular disease, and clinical cardiac electrophysiology. She is a staff Clinical Cardiac Electrophysiologist in the Heart and Vascular Institute Department of Cardiovascular Medicine and in the Lerner Research Institute Department of Molecular Cardiology at the Cleveland Clinic. She is a Professor of Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Chung is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. She is also active on committees within the American Heart Association (AHA), American College of Cardiology (ACC) and the Heart Rhythm Society (HRS). She has been Chair of the HRS Scientific and Clinical Documents Committee and is a member of the AHA Electrocardiology and Arrhythmias Committee of the Clinical Cardiology Council, the ACC Electrophysiology Section Leadership Council, and the Cleveland Clinic Institutional Review Board. She has served on several consensus document and guideline writing committees and the National Institutes of Health (NIH) Clinical Trial Review Committee.
Dr. Chung has authored or co-authored numerous peer-reviewed publications. Her research interests include translational genomics of atrial fibrillation, clinical arrhythmia outcomes and electrophysiology device and ablation outcomes. She is a principal investigator for an NIH-funded grant on functional genomics of atrial fibrillation.
Dr. Chung received a bachelor's degree in chemistry from the University of California, San Diego, and her medical degree from Washington University School of Medicine in St. Louis, Missouri, where she also completed internal medicine residency and chief residency and cardiology and cardiac electrophysiology fellowships.
As of July 2022, Dr. Chung reported the following external relationships:
Work as an author or editor for the following companies, with compensation as listed:
- The American Heart Association, receiving compensation as Associate Editor, Circulation: Arrhythmias & Electrophysiology
- Elsevier, receiving compensation for authorship
- UpToDate®, receiving compensation for authorship
Dr. Chung serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American College of Cardiology, Appropriate Use Criteria for ICDs and CRT Writing Group, Member, without compensation
- The American Heart Association, Arrhythmia and Electrocardiogram Committee Chair; Committee on Scientific Sessions Program, Member; Atrial Fibrillation Systems of Care Advisory Group, Member; Scientific Statement on Lifestyle and Risk Factor Modification to Reduce Atrial Fibrillation, Chair; Scientific Statement on Drug-Induced Arrhythmias, Vice Chair; Writing Group, Member, “Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association;” Writing Committee, ISHNE/ISE/HRS “Electrocardiology of Channelopathies and Inherited Arrhythmia Disorders,” without compensation
- French National Research Agency, grant review panel member, to receive honoraria
- The Heart Rhythm Society, Board of Trustees, COVID-19 Rapid Response Task Force, liaison to Research Committee, Chair, guideline on cardiac physiologic pacing, receiving reimbursement for travel expenses
Funding from nonprofit healthcare-related organizations for clinical trial expenses, salary support and staff, paid to the Cleveland Clinic, from the following organizations:
- The American Heart Association, for an atrial fibrillation strategically focused research network grant and for COVID-19 research grants
- The National Institutes of Health, for R01 research grants
Dr. Chung also reported presenting at Columbia University Cardiology Grand Rounds, Northwell Health Cardiology Grand Rounds and a Geisinger Physiology of Pacing Symposium.
Paul L. Douglass, MD
Dr. Douglass is a native of Nashville, Tennessee. He joined Metropolitan Atlanta Cardiology Consultants in 1982 and practices Clinical and Interventional Cardiology. Dr. Douglass is Chief, Division of Cardiology and Director, Cardiovascular Services at the Atlanta Medical Center. He is also a past Chairman of the Hospital Board at Atlanta Medical Center. He serves as Clinical Assistant Professor (Cardiology) at Morehouse School of Medicine.
He has been the recipient of numerous professional awards including the Physician of the Year Award and the Nash – Carter Award from the Atlanta Medical Association; the Distinguished Service Medallion from the Georgia State Medical Association; several years of Teaching Excellence Awards from the Department of Internal Medicine at Atlanta Medical Center; and the Hero Award from the Association of Black Cardiologists. Dr. Douglass has worked diligently on behalf of cardiovascular medicine, serving on the National Heart Lung Blood Institute Advisory Panel and the Special Emphasis Panel and Disparities Working Group. He was instrumental in the planning and establishment of the Georgia chapter of the American College of Cardiology (ACC) and served as its first Secretary – Treasurer. He also became President and Governor of the Georgia chapter of the ACC. Dr. Douglass has participated on numerous committees and task forces for the American College of Cardiology and completed his term as Chair of the Credentials and Membership Committee in 2006. He was also appointed to the Board of Trustees of the ACC. Dr. Douglass is the chair of the Publications Committee for the Journal of the American College of Cardiology. He is past President of the Metro Atlanta American Heart Association; he has served as president of the Atlanta Medical Association, President of the Georgia State Medical Association, and National President of the Association of Black Cardiologists. He currently serves on the Board of Trustees of WellStar Healthcare System.
He received his undergraduate degree in biology from Northwestern University. His medical degree was awarded at Meharry Medical College. He was elected to Alpha Omega Alpha Honor Society in 1976. Dr. Douglass did his postgraduate training in internal medicine and cardiovascular diseases at Emory University School of Medicine between 1976 and 1982.
As of July 2022, Dr. Douglass reported the following external relationships:
Dr. Douglass serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American College of Cardiology, Industry Advisory Committee, Member; Health Equity Taskforce, Member, receiving reimbursement for travel expenses
- The American Heart Association, Heart Failure Systems of Care Advisory Group, Member, without compensation
- Wellstar Health System, Board of Trustees, receiving reimbursement for travel expenses
William Lane Duvall, MD
Dr. Duvall is the Director of Nuclear Cardiology at Hartford Hospital in Hartford, Connecticut, and Associate Professor of Medicine at the University of Connecticut School of Medicine. He is board certified in internal medicine, cardiovascular disease, nuclear cardiology and adult echocardiography.
Previously, Dr. Duvall worked as a non-invasive cardiologist at Mount Sinai Medical Center for almost 10 years, most recently serving as an Associate Professor of Medicine. During his time there, he worked full-time in the echocardiography and nuclear cardiology laboratories and served in several administrative positions including in the fellowship program and the cardiac care unit.
Dr. Duvall is a member of the American Board of Internal Medicine Cardiovascular Board Cardiovascular Disease Exam Committee. He is actively involved with the American Society of Nuclear Cardiology, currently serving on the Board of Directors. Additionally, he is a member of the Registry Oversight Committee and the Deputy Chair of the Health Policy Committee.
Dr. Duvall received a bachelor’s degree in molecular biology from Princeton University and his medical degree from Yale University. He completed his internal medicine internship and residency at Duke University Medical Center, and his cardiovascular disease fellowship at Mount Sinai Medical Center in New York City.
As of July 2022, Dr. Duvall reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Hartford Hospital, from the following companies:
- GE Medical, providing their nuclear imaging quantification software to be used for several research projects.
Teaching in satellite symposia funded by the following companies, with honoraria:
- GE Medical, for an educational lecture PET/CT and SPECT/CT.
Dr. Duvall serves in significant roles with the following organization, receiving reimbursement or compensation as listed:
- The American Society of Nuclear Cardiology, Board of Directors, Health Care Policy Committee, ImageGuide Registry Committee, receiving reimbursement for travel expenses.
Garrie J. Haas, MD, FACC
Dr. Haas is Professor of Clinical Medicine at The Ohio State University Wexner Medical Center in Columbus, Ohio. He is the Section Chief of the Advanced Heart Failure and Cardiac Transplant Program at Ohio State, and is the Medical Director of Heart Failure for the Wexner Medical Center. Dr. Haas is board certified in internal medicine, cardiovascular disease, and advanced heart failure & transplant cardiology.
He was formerly the Director of the Heart Failure Intensive Care Unit at Cleveland Clinic, and directed the heart failure disease management program at Riverside Methodist Hospital in Columbus.
Dr. Haas is a member of the American Board of Internal Medicine Cardiovascular Disease Traditional, 10-Year MOC Exam Approval Committee. Previously, he held the directorship of the Heart and Vascular Research Organization (HVRO) at Ohio State, which manages over 150 clinical trials for the divisions of cardiology, cardiovascular surgery and vascular medicine. He is personally actively involved as principal investigator for multiple heart failure clinical trials. Dr. Haas is a member of the heart failure subcommittee of the American College of Cardiology-affiliated Society of Cardiovascular Patient Care. He was previously the Chair of the Heart Failure version 3 writing committee for the American College of Cardiology.
Dr. Haas received his degree in zoology from Ohio Wesleyan University, and earned his medical degree from Marshall University in Huntington, West Virginia. He completed his medicine residency at The Ohio State University College of Medicine. Dr. Haas also completed fellowships in cardiology, interventional cardiology and heart failure/cardiac transplantation at Ohio State’s College of Medicine.
As of June 2023, Dr. Haas reported the following external relationships:
Funding for clinical trial expenses and staff, paid to Ohio State University, from the following companies:
- V-Wave, for a study to reduce lung congestion symptoms using a shunt in advanced heart failure
- DCM Precision Medicine, receiving salary support
Work as an author or editor for the following company, with compensation as listed:
- Springer, receiving compensation as editor for Management of Heart Failure
Scott Kinlay, MBBS, Ph.D.
Dr. Kinlay is the Chief of Cardiovascular Medicine and Director of the Cardiac Catheterization Laboratory and Vascular Medicine at VA Boston Healthcare System, and an Associate Professor of Medicine at Harvard Medical School. Dr. Scott Kinlay is a board certified cardiologist and interventional cardiologist with expertise in invasive and noninvasive vascular medicine. He is board certified by the American Board of Internal Medicine in Internal Medicine, Cardiology and Interventional Cardiology, and by the American Board of Vascular Medicine in General Vascular Medicine and Endovascular Medicine. He is a Registered Physician in Vascular Interpretation.
Dr. Kinlay’s clinical interests include interventional cardiology and intravascular imaging, and the noninvasive and endovascular treatment of peripheral vascular disease. His research interests are in clinical outcomes after coronary and peripheral interventions, particularly in veterans treated in the VA Healthcare System, lipid lowering therapies, and endothelial and vascular function.
Dr. Kinlay completed his medical degree at the University of Sydney School of Medicine in Australia and a residency at Royal Newcastle Hospital. He completed fellowships in internal medicine and cardiology at John Hunter Hospital, Newcastle, in Australia, and an interventional cardiology fellowship at Brigham and Women’s Hospital in Boston.
As of January 2021, Dr. Kinlay reported the following external relationships:
Dr. Kinlay serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American Heart Association, Editor of Circulation Cardiovascular Interventions, without compensation
- American College of Cardiology, Peripheral Vascular Disease Committee Member, without compensation
- Society for Vascular Medicine, Abstract Review Committee Member, without compensation
Aniruddha Singh, MD
Dr. Singh is the Program Director for the General Cardiovascular Fellowship program at Drexel University College of Medicine at Tower Health in West Reading, Pennsylvania. He is board certified in Cardiology, Internal Medicine, Echocardiography, Cardiac Computed Tomography, Nuclear Cardiology and Vascular Ultrasonography and has earned a Master in Lipidology through the National Lipid Association. Dr. Singh serves on various state and national committees with the American College of Cardiology and the National Lipid Association, and also volunteers as a Content Expert for the Alliance for Physician Certification & Advancement. Previously, Dr. Singh was Assistant Professor of Medicine and Research Chairman for the GME programs at the University of Kentucky College of Medicine in Bowling Green, Kentucky. He was the Internal Medicine Clerkship Director for third- and fourth-year medical students and later transitioned to the role of Associate Program Director of the Cardiovascular Fellowship.
Dr. Singh has a special interest in exam-designing and enhancing health care quality. Since 2019, he has worked closely with the American Board of Internal Medicine in various capacities: Standard Setting, the Item-Writing Task Force for Cardiovascular Disease and Fairness Review.
Dr. Singh received his medical degree from Jawaharlal Nehru Medical College in India. He completed an internal medicine residency at Saint Vincent Hospital in Worcester, Massachusetts, including one year as chief resident. He completed his cardiology fellowship at the University of Connecticut Health Center. He also holds a Master of Business Administration from the University of Kentucky.
As of May 2023, Dr. Singh reported the following external relationships:
Dr. Singh serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- American College of Cardiology, Accreditation, Awards and PDGME Leadership Council Member, without compensation.
Chittur A. Sivaram, MD
Dr. Chittur A. ('C.A.') Sivaram is a David Ross Professor at University of Oklahoma and serves as the Vice Chief of the Cardiovascular Section for Education and Training (Department of Medicine) and Associate Dean for Continuing Professional Development at the University of Oklahoma (OU) College of Medicine.
He served on the faculty of Texas Tech University at the Amarillo Campus for 9 years, and has been at University of Oklahoma since 1993. He is involved with student, resident and fellow education at OU, and has mentored many trainees and received multiple teaching awards.
Dr. Sivaram is very active with the American College of Cardiology (ACC) both at the state and national levels, having served as a past Chair of Cardiovascular Fellowship Program Directors group. He was the national Chair for the ABIM’s Competency Based Pilot in Internal Medicine/Cardiology. He was recognized with the Gifted Educator Award from ACC (2015) and the Laennec Master Clinician Award from AHA (2017). He maintains an active clinical practice at OU Physicians and is sought after locally for his expertise in the field of echocardiography.
He obtained his medical degree and cardiology training from India, and underwent additional residency and cardiology fellowship training from Canada (Memorial University and University of Alberta).
As of July 2022, Dr. Sivaram reported the following external relationships:
Dr. Sivaram serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:
- The American College of Cardiology, Leadership Council of Senior Cardiovascular Professionals Section, without compensation
- The American Heart Association, FIT PD Workgroup, Chair, without compensation